This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Complications

Authoring team

  • post-herpetic neuralgia may be seen following herpes zoster infection
    • defined as pain persisting 3 months or more after resolution of the cutaneous HZ lesions.
    • is the most common complication
    • incidence and severity increases with age
  • temporary paralysis (1-5%) usually follows the dermatome involved and may affect bladder and bowel function
  • disseminated HZ occurs primarily in immunocompromised patients; it usually presents with a dermatomal eruption followed by dissemination but may also present with a diffuse varicella-like eruption (1)
    • systemic dissemination may accompany the skin changes with involvement of the lung, liver, and brain
  • visceral dissemination is associated with a mortality rate of 5% to 15%, with most deaths attributable to pneumonia
  • neurologic complications of HZ may include:
    • acute or chronic encephalitis
    • myelitis
    • aseptic meningitis
    • polyradiculitis
    • retinitis
    • autonomic dysfunction
    • motor neuropathies
    • Guillain-Barre syndrome
    • hemiparesis
    • cranial or peripheral nerve palsies
  • more common complications include bacterial superinfection by Staphylococcus aureus or Streptococcus pyogenes, scarring, and hyperpigmentation
    • secondary infection - especially dangerous in the ophthalmic division.

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.